aVaxziPen

aVaxziPen Focuses on Next-Generation Vaccines for Infectious Diseases and Emerging Threat Pathogens. aVaxziPen is developing next-generation vaccination products enabled by its proprietary aVaxziPen® technology, targeting infectious diseases and urgent threat pathogens. aVaxziPen creates and delivers vaccines in needle-free, thermostable, solid-dose formats suitable for all types of vaccines. Our goal is to transform vaccine delivery using needle-free doses, reducing or eliminating the need for cold chain storage, thereby creating a lasting positive impact on global health.